Unknown

Dataset Information

0

Risk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinoma.

ABSTRACT: To determine risk factors associated with recurrence in patients with high intermediate risk (HIR) endometrioid adenocarcinoma.A retrospective analysis of patients with HIR endometrioid adenocarcinoma who underwent hysterectomy, bilateral salpingo-oophorectomy, with or without pelvic/para-aortic lymphadenectomy at the University of Pennsylvania between 1990 and 2009 was performed.A total of 103 women with HIR endometrial cancer were identified. Multivariable analysis revealed that ?2/3 myometrial invasion (HR, 4.79; p=0.010) and grade 3 disease (HR, 3.04; p=0.045) were independently predictive of distant metastases. The 5-year distant metastases free survival (DMFS) for patients with neither or one of these risk factors was 89%, and the 5-year DMFS for patients with both risk factors was 48% (p<0.001).Patients with both grade 3 disease and deep third myometrial invasion have a high risk of distant metastases. Identifying these patients may be important in rationally selecting patients for systemic therapy.

SUBMITTER: Bahng AY 

PROVIDER: S-EPMC3469861 | biostudies-other | 2012 Oct

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

Risk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinoma.

Bahng Agnes Y AY   Chu Christina C   Wileyto Paul P   Rubin Stephen S   Lin Lilie L LL  

Journal of gynecologic oncology 20120919 4

<h4>Objective</h4>To determine risk factors associated with recurrence in patients with high intermediate risk (HIR) endometrioid adenocarcinoma.<h4>Methods</h4>A retrospective analysis of patients with HIR endometrioid adenocarcinoma who underwent hysterectomy, bilateral salpingo-oophorectomy, with or without pelvic/para-aortic lymphadenectomy at the University of Pennsylvania between 1990 and 2009 was performed.<h4>Results</h4>A total of 103 women with HIR endometrial cancer were identified. M  ...[more]

Similar Datasets

Transcriptomics BreastPRS is a Gene Expression Assay that Stratifies Intermediate-Risk Oncotype DX Patients into High or Low-Risk for Disease Recurrence
2013-06-23 | E-GEOD-47109 | biostudies-arrayexpress
Transcriptomics BreastPRS is a Gene Expression Assay that Stratifies Intermediate-Risk Oncotype DX Patients into High or Low-Risk for Disease Recurrence
2013-06-23 | GSE47109 | GEO
Unknown The baseline recurrence risk of patients with intermediate-risk cervical cancer.
| S-EPMC7991004 | biostudies-literature
Transcriptomics A 4-gene signature associated with recurrence risk in patients with low and intermediate-risk endometrial cancer
2021-07-27 | GSE178671 | GEO
Unknown BreastPRS is a Gene Expression Assay that Stratifies Intermediate-Risk Oncotype DX Patients into High or Low-Risk for Disease Recurrence
| S-ECPF-GEOD-47109 | biostudies-other
Unknown Predicting high-risk endometrioid carcinomas using proteins.
| S-EPMC5929419 | biostudies-literature
Unknown Identifying a molecular profile to predict the risk of recurrence in high-intermediate risk endometrial cancer.
| S-EPMC8607249 | biostudies-literature
Unknown Squamous differentiation portends poor prognosis in low and intermediate-risk endometrioid endometrial cancer.
| S-EPMC6786591 | biostudies-literature
Other miRs expression profile to predict HNSCC patients at high risk to develop recurrence
2017-10-02 | GSE89000 | GEO
Unknown Risk factors for pleural effusion recurrence in patients with malignancy.
| S-EPMC7315912 | biostudies-literature